Article

Identification of SARS-CoV2-mediated suppression of NRF2 signaling reveals a potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate

2020-05-27

Abstract excerpt

Antiviral strategies to inhibit Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and the pathogenic consequences of COVID-19 are urgently required. Here we demonstrate that the NRF2 anti-oxidant gene expression pathway is suppressed in biopsies obtained from COVID-19 patients. Further, we uncover that NRF2 agonists 4-octyl-itaconate (4-OI) and the clinically approved dimethyl fumarate (DMF) induce a pot...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cc403e96-f07c-51d7-9b37-4352df29f0ab
DOI: 10.21203/rs.3.rs-31855/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of SARS-CoV2-mediated suppression of NRF2 signaling reveals a potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarateDOI 10.21203/rs.3.rs-31855/v1Read

Identification of SARS-CoV2-mediated suppression of NRF2 signaling reveals a potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarateSemantic proximity Read

The Role of the NRF2 Pathway in the Pathogenesis of Viral Respiratory InfectionsSemantic proximity Read

Transcription factor Nrf2 as a potential therapeutic target for COVID-19Semantic proximity Read

NRF2 activators restrict coronaviruses by targeting a network involving ACE2, TMPRSS2, and XPO1Semantic proximity Read

NRF2 Antioxidant Response and Interferon‐Stimulated Genes Are Differentially Expressed in SARS‐CoV‐2‐Positive Young SubjectsSemantic proximity Read

Pharmacological inhibition of bromodomain and extra-terminal proteins induces NRF-2-mediated inhibition of SARS-CoV-2 replication and is subject to viral antagonismSemantic proximity Read

Nrf2 Activator PB125 <sup>®</sup> as a Potential Therapeutic Agent Against COVID-19Semantic proximity Read

Nrf2 activator PB125® as a carnosic acid-based therapeutic agent against respiratory viral diseases, including COVID-19Semantic proximity Read

Nrf2 Activator PB125® as a Potential Therapeutic Agent against COVID-19Semantic proximity Read

Nrf2-dependent induction of innate host defense via heme oxygenase-1 inhibits Zika virus replicationSemantic proximity Read

SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1Semantic proximity Read

SARS-CoV-2 Nsp2 Contributes to Inflammation by Activating NF-κBSemantic proximity Read